Parameter [unit] | Placebo (N = 19) | Ambrisentan (N = 19) |  | Total (N = 38) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | 95% CI | n | Mean ± SD | 95% CI | n | 95% CI of difference | Mean ± SD | 95% CI | n | |
Female sex no. [%] | 14 (73.7) | Â | Â | 16 (84.2) | Â | Â | Â | 30 (78.9) | Â | Â |
Age [years] | 54.89 ± 11.23 | (49.48 to 60.31) |  | 58.79 ± 10.75 | (53.61 to 63.97) |  | (− 3.33 to 11.12) | 56.84 ± 11.02 | (53.22 to 60.46) |  |
Height [cm] | 166.21 ± 10.19 | (161.30 to 171.12) |  | 166.05 ± 5.59 | (163.36 to 168.75) |  | (− 5.62 to 5.31) | 166.13 ± 8.11 | (163.47 to 168.80) |  |
Weight [kg] | 74.81 ± 17.25 | (66.48 to 83.10) |  | 71.45 ± 15.83 | (64.03 to 79.22) |  | (− 14.03 to 7.70) | 73.13 ± 16.42 | (67.83 to 78.59) |  |
Systolic blood pressure [mmHg] | 121.32 ± 14.99 | (114.09 to 128.54) |  | 116.32 ± 11.53 | (110.76 to 121.87) |  | (− 13.80 to 3.80) | 118.82 ± 13.43 | (114.40 to 123.23) |  |
Diastolic blood pressure [mmHg] | 73.42 ± 9.14 | (69.02 to 77.82) |  | 73.68 ± 8.95 | (69.37 to 78.00) |  | (− 5.69 to 6.21) | 73.55 ± 8.92 | (70.62 to 76.49) |  |
HR [beats/min] | 77.58 ± 9.85 | (72.83 to 82.33) |  | 73.05 ± 11.12 | (67.69 to 78.41) |  | (− 11.44 to 2.39) | 75.32 ± 10.61 | (72.83 to 78.81) |  |
WHO-FC no. [%] | ||||||||||
 II | 15 (78.9) |  |  | 17 (89.5) |  |  |  | 32 (84.2) |  |  |
 III | 4 (21.1) |  |  | 2 (10.5) |  |  |  | 6 (15.8) |  |  |
Hemodynamic characteristic according to inclusion criteria | ||||||||||
 mPAP rest 21–24 mmHg, mPAP exercise > 30 mmHg | 12 (63.2) |  |  | 10 (52.6) |  |  |  | 22 (57.9) |  |  |
 mPAP rest 21–24 mmHg, mPAP exercise ≤ 30 mmHg | 3 (15.8) |  |  | 1 (5.3) |  |  |  | 4 (10.5) |  |  |
 mPAP rest < 21 mmHg, mPAP exercise > 30 mmHg | 4 (21.0) |  |  | 8 (42.1) |  |  |  | 2 (31.6) |  |  |
 mRSS [points] | 11.47 ± 5.22 | (8.72 to 14.23) |  | 11.47 ± 5.71 | (8.96 to 13.99) |  | (− 3.60 to 3.60) | 11.47 ± 5.40 | (9.70 to 13.25) |  |
SSc subgroup, no. (%) | ||||||||||
 Diffuse | 11 (57.9) |  |  | 4 (21.1) |  |  |  | 15 (39.5) |  |  |
 Limited | 8 (42.1) |  |  | 15 (78.9) |  |  |  | 23 (60.5) |  |  |
 SSc disease duration [years] | 13.28 ± 10.85 | (8.05 to 18.51) |  | 6.63 ± 4.80 | (4.32 to 8.96) |  | (− 12.17 to 1.12) | 9.96 ± 8.93 | (7.02 to 12.90) |  |
Hemodynamics at rest | ||||||||||
 CVP [mmHg] | 5.63 ± 2.97 | (4.20 to 7.06) |  | 6.11 ± 2.94 | (4.69 to 7.52) |  | (− 1.47 to 2.41) | 5.87 ± 2.92 | (4.90 to 6.82) |  |
 mPAP [mmHg] | 21.32 ± 2.43 | (20.15 to22.49) |  | 19.84 ± 3.58 | (18.12 to 21.57) |  | (− 3.49 to 0.54) | 20.58 ± 3.11 | (19.56 to 21.60) |  |
 PAWP [mmHg] | 9.58 ± 2.97 | (8.15 to 11.01) |  | 9.42 ± 2.32 | (8.30 to 10.54) |  | (− 1.91 to 1.59) | 9.50 ± 2.63 | (8.64 to 10.37) |  |
 CO [l/min] | 5.66 ± 1.48 | (4.95 to 6.37) |  | 5.04 ± 1.26 | (4.43 to 5.65) |  | (− 1.51 to 0.29) | 5.35 ± 1.39 | (4.89 to 5.81) |  |
 CI [l/min/m2] | 3.20 ± 0.85 | (2.79 to 3.61) |  | 2.84 ± 0.64 | (2.53 to 3.14) |  | (− 0.86 to 0.13) | 3.02 ± 0.76 | (2.77 to 3.27) |  |
 SvO2 [%] | 73.13 ± 4.60 | (70.67 to 75.58) | (16) | 73.91 ± 8.58 | (69.50 to 78.32) | (17) | (− 4.15 to 5.71) | 73.53 ± 6.85 | (71.10 to 75.96) | (33) |
 PVR [WU] | 2.09 ± 0.61 | (1.80 to 2.39) |  | 2.22 ± 0.93 | (1.77 to 2.67) |  | (− 0.39 to 0.65) | 2.16 ± 0.78 | (1.90 to 2.41) |  |
Hemodynamics at peak exercise | ||||||||||
 mPAP [mmHg] | 36.94 ± 6.08 | (33.82 to 40.07) | (17) | 37.78 ± 3.61 | (35.98 to 39.57) | (18) | (− 2.58 to 2.25) | 37.37 ± 4.91 | (35.69 to 39.06) | (35) |
 PAWP [mmHg] | 15.24 ± 5.43 | (12.45 to 18.03) | (17) | 16.78 ± 6.42 | (13.58 to 19.97) | (18) | (− 2.56 to 5.64) | 16.03 ± 5.92 | (13.99 to 18.06) | (35) |
 CO [l/min] | 11.03 ± 3.62 | (9.17 to 12.89) | (17) | 9.67 ± 2.67 | (8.34 to 10.99) | (18) | (− 3.54 to 0.81) | 10.33 ± 3.19 | (9.23 to 11.43) | (35) |
 CI [l/min/m2] | 6.04 ± 1.79 | (5.12 to 6.96) | (17) | 5.41 ± 1.32 | (4.75 to 6.06) | (18) | (− 1.71 to 0.45) | 5.71 ± 1.58 | (5.17 to 6.25) | (35) |
 SvO2 [%] | 38.27 ± 6.10 | (34.89 to 41.64) | (15) | 42.77 ± 11.56 | (36.36 to 49.17) | (15) | (− 2.42 to 11.42) | 40.52 ± 9.37 | (37.02 to 44.02) | (30) |
 Workload [Watt] | 75.00 ± 34.23 | (57.40 to 92.60) | (17) | 75.00 ± 27.12 | (61.52 to 88.48) | (18) | (− 21.18 to 21.17) | 75.00 ± 30.32 | (65.59 to 85.41) | (35) |
 HR max [/min] | 117.65 ± 21.37 | (106.66 to 128.63) | (17) | 111.39 ± 23.06 | (99.92 to 122.86) | (18) | (− 21.57 to 9.06) | 114.43 ± 22.15 | (106.82 to 122.04) | (35) |
 PVR [WU] | 2.07 ± 0.61 | (1.76 to 2.38) | (17) | 2.29 ± 0.85 | (1.87 to 2.71) | (18) | (− 0.29 to 0.73) | 2.18 ± 0.74 | (1.93 to 2.44) | (35) |
 TPR [mmHg min l− 1] | 3.65 ± 1.18 | (3.04 to 4.26) | (17) | 4.28 ± 1.65 | (3.46 to 5.10) | (18) | (− 0.36 to 1.62) | 3.97 ± 1.46 | (3.47 to 4.47) | (35) |
6MWD | ||||||||||
 6MWD [m] | 448.11 ± 82.64 | (408.28 to 487.93) |  | 470.21 ± 77.03 | (433.08 to 407.34) |  | (− 30.46 to 74.67) | 459.16 ± 79.59 | (433.00 to 485.32) |  |
 Borg dyspnea score | 2.93 ± 1.97 | (1.98 to 3.88) |  | 2.41 ± 1.32 | (1.77 to 3.04) |  | (− 1.63 to 0.58) | 2.67 ± 1.68 | (2.11 to 3.22) |  |
 SaO2 after 6MWD [%] | 91.87 ± 4.63 | (89.30 to 94.43) | (15) | 91.71 ± 4.79 | (89.24 to 94.17) | (17) | (− 3.57 to 3.25) | 91.78 ± 4.64 | (90.10 to 93.45) | (32) |
 HR after 6MWD [/min] | 99 ± 21.27 | (88.07 to 109.93) | (17) | 107 ± 19.64 | (96.90 to 117.10) | (17) | (− 6.30 to 22.30) | 103 ± 20.56 | (95.82 to 110.17) | (34) |
Echocardiography at rest | ||||||||||
 Estimated sPAP [mmHg] | 29.21 ± 5.16 | (25.25 to 31.17) |  | 28.58 ± 6.57 | (26.04 to 31.43) |  | (− 4.52 to 3.26) | 28.89 ± 5.83 | (26.98 to 30.81) |  |
 RA area [cm2] | 12.05 ± 4.24 | (10.73 to 13.69) |  | 11.68 ± 3.28 | (10.45 to 13.66) |  | (− 2.86 to 2.13) | 11.87 ± 3.74 | (10.64 to 13.10) |  |
 RV area [cm2] | 14.89 ± 4.56 | (12.97 to 17.03) |  | 14.13 ± 4.74 | (12.65 to 16.82) |  | (− 3.82 to 2.30) | 14.51 ± 4.60 | (13.00–16.03) |  |
 TAPSE [cm] | 2.50 ± 0.51 | (2.23 to 2.71) |  | 2.41 ± 0.33 | (2.28 to 2.70) |  | (− 0.37 to 0.20) | 16,834 ± 0.43 | (2.31 to 2.60) |  |
Lung function | ||||||||||
 FVC [%] | 69.17 ± 13.72 | (62.56 to 75.78) |  | 70.51 ± 17.61 | (62.02 to 79.00) |  | (− 6.37 to 1.84) | 69.84 ± 15.58 | (64.72 to 74.96) |  |
 FEV1 [L] | 2.40 ± 0.77 | (2.03 to 2.77) |  | 2.26 ± 0.63 | (1.96 to 2.57) |  | (− 0.60 to 0.33) | 2.33 ± 0.70 | (2.10 to 2.56) |  |
 FEV1% VC max [%] | 79.31 ± 6.98 | (75.95 to 82.68) |  | 81.44 ± 15.38 | (74.03 to 88.85) |  | (− 5.73 to 9.99) | 80.38 ± 11.83 | (76.49 to 84.27) |  |
 PEF [l/s] | 5.46 ± 2.32 | (4.34 to 6.58) |  | 5.17 ± 1.72 | (4.34 to 6.00) |  | (− 1.63 to 1.06) | 5.31 ± 2.02 | (4.65 to 5.98) |  |
 TLC [l] | 4.96 ± 1.07 | (4.44 to 5.48) |  | 5.08 ± 1.25 | (4.48 to 5.69) |  | (− 0.64 to 0.89) | 5.02 ± 1.15 | (4.64 to 5.40) |  |
 Residual volume [l] | 1.94 ± 0.55 | (1.68 to 2.21) |  | 2.18 ± 0.70 | (1.84 to 2.52) |  | (− 0.18 to 0.65) | 2.06 ± 0.63 | (1.85 to 2.27) |  |
 DLCO [mmol/min/kPa] | 5.28 ± 1.52 | (4.55 to 6.02) |  | 5.03 ± 1.33 | (4.38 to 5.67) |  | (− 1.20 to 0.68) | 5.16 ± 1.42 | (4.69 to 5.62) |  |
 DLCO % predicted | 84.73 ± 2.61 | (83.47 to 85.99) |  | 84.16 ± 1.89 | (83.25 to 85.08) |  | (− 2.07 to 0.93) | 84.45 ± 2.27 | (83.70 to 85.19) |  |
 SaO2 [%] | 96.13 ± 1.80 | (95.26 to 97.00) |  | 96.82 ± 0.77 | (96.45 to 97.17) |  | (− 0.23 to 1.60) | 96.47 ± 1.41 | (96.01 to 96.94) |  |
 PaO2 [mmHg] | 78.78 ± 9.42 | (74.24 to 83.32) |  | 81.22 ± 5.91 | (78.37 to 84.06) |  | (− 2.74 to 7.61) | 80.00 ± 7.85 | (77.42 to 82.58) |  |
 PaCO2 [mmHg] | 39.01 ± 3.63 | (37.25 to 40.76) |  | 37.23 ± 2.57 | (35.99 to 38.47) |  | (− 3.85 to 0.29) | 38.12 ± 3.23 | (37.05 to 39.18) |  |
Laboratory | ||||||||||
 Hemoglobin [g/dl] | 13.54 ± 1.26 | (12.93 to 14.14) |  | 13.62 ± 1.13 | (13.07 to 14.16) |  | (− 0.71 to 0.87) | 13.58 ± 1.18 | (13.19 to 13.96) |  |
 Hematocrit [l/l] | 0.42 ± 0.03 | (0.40 to 0.43) |  | 0.41 ± 0.03 | (0.40 to 0.43) |  | (− 0.03 to 0.02) | 0.41 ± 0.03 | (0.40 to 0.42) |  |
 Platelet [100/nl] | 2.53 ± 0.94 | (2.08 to 2.98) |  | 2.62 ± 0.63 | (2.31 to 2.92) |  | (− 0.44 to 0.61) | 2.58 ± 0.79 | (2.32 to 2.83) |  |
 Creatinine [mg/dl] | 0.83 ± 0.16 | (0.75 to 0.91) |  | 0.86 ± 0.12 | (0.80 to 0.92) |  | (− 0.07 to 0.13) | 0.85 ± 0.14 | (0.80 to 0.89) |  |
 Potassium [mmol/l] | 4.05 ± 0.38 | (3.86 to 4.23) |  | 4.20 ± 0.48 | (3.97 to 4.43) |  | (− 0.13 to 0.44) | 4.12 ± 0.43 | (3.98 to 4.27) |  |
 AST [U/l] | 24.11 ± 21.78 | (13.61 to 34.60) |  | 19.79 ± 7.06 | (16.39 to 23.19) |  | (− 14.97 to 6.34) | 21.95 ± 16.12 | (16.65 to 27.25) |  |
 ALT [U/l] | 29.68 ± 24.93 | (17.67 to 41.70) |  | 24.68 ± 9.85 | (19.93 to 29.43) |  | (− 17.47 to 7.47) | 27.18 ± 18.87 | (20.98 to 33.39) |  |
 LDH [U/l] | 197.63 ± 54.74 | (171.25 to 224.01) |  | 197.53 ± 35.59 | (180.37 to 214.68) |  | (− 30.48 to 30.27) | 197.58 ± 45.54 | (182.61 to 212.55) |  |
 CRP [mg/l] | 5.18 ± 5.17 | (2.69 to 7.68) |  | 5.28 ± 11.60 | (− 0.48 to 11.05) | (18) | (− 5.84 to 6.04) | 5.23 ± 8.77 | (2.30 to 8.16) | (37) |
 NTproBNP [pg/ml] | 123.42 ± 142.96 | (54.52 to 192.32) |  | 267.83 ± 303.11 | (117.10 to 418.57) | (18) | (− 12.38 to 301.20) | 193.68 ± 242.81 | (112.71 to 274.63) | (37) |
Quality of life SF-36 | ||||||||||
 Physical functioning | 50.26 ± 25.95 | (37.75 to 62.77) |  | 64.21 ± 25.83 | (51.67 to 76.66) |  | (− 3.09 to 30.99) | 57.24 ± 26.50 | (48.52 to 65.95) |  |
 Physical role functioning | 35.53 ± 40.24 | (16.13 to 54.92) |  | 51.32 ± 41.23 | (31.45 to 79.19) |  | (− 11.01 to 42.59) | 43.42 ± 40.97 | (29.96 to 56.89) |  |
 Bodily pain | 49.79 ± 28.96 | (35.83 to 63.75) |  | 62.00 ± 29.16 | (47.95 to 76.05) |  | (− 6.91 to 31.33) | 55.89 ± 29.33 | (46.26 to 65.53) |  |
 General health perceptions | 41.74 ± 13.07 | (35.44 to 48.04) |  | 54.42 ± 19.47 | (45.03 to 63.81) |  | (1.72 to 23.65) | 48.08 ± 17.58 | (42.30 to 53.86) |  |
 Vitality | 42.89 ± 19.32 | (33.58 to 52.20) |  | 50.53 ± 20.94 | (40.03 to 60.62) |  | (− 5.62 to 20.89) | 46.71 ± 20.24 | (40.06 to 53.37) |  |
 Social role functioning | 58.05 ± 25.99 | (45.53 to 70.58) |  | 74.47 ± 24.45 | (62.69 to 86.26) |  | (− 0.18 to 33.03) | 66.26 ± 26.24 | (57.64 to 74.89) |  |
 Emotional role functioning | 49.16 ± 46.33 | (26.83 to 71.49) |  | 63.16 ± 47.02 | (40.50 to 85.82) |  | (− 16.71 to 44.71) | 56.16 ± 46.58 | (40.85 to 71.47) |  |
 Mental health | 59.58 ± 18.85 | (50.49 to 68.66) |  | 64.42 ± 18.03 | (55.73 to 73.11) |  | (− 7.30 to 16.98) | 62.00 ± 18.36 | (55.97 to 68.04) |  |
 Physical health score | 43.89 ± 21.26 | (33.65 to 54.14) |  | 56.47 ± 23.87 | (44.97 to 67.98) |  | (− 2.29 to 27.45) | 50.18 ± 23.19 | (42.56 to 57.81) |  |
 Mental health score | 50.26 ± 20.70 | (40.29 to 60.24) |  | 61.42 ± 21.45 | (51.08 to 71.76) |  | (− 2.71 to 25.03) | 55.84 ± 21.55 | (48.76 to 62.92) |  |